Back to search

Article

Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation

2021-05-01

Abstract excerpt

Major histocompatibility complex (MHC)-bound peptides that originate from tumor-specific genetic alterations, known as neoantigens, are an important class of anti-cancer therapeutic targets. Accurately predicting peptide presentation by MHC complexes is a key aspect of discovering therapeutically relevant neoantigens. Technological improvements in mass-spectrometry-based immunopeptidomics and advanced modeling tec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
70624a50-9feb-5f9d-b6e4-c879d336de6c
DOI
10.1101/2021.04.30.442203
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentationDOI 10.1101/2021.04.30.442203
Select a neighboring publication to make it the new centre.